Rapid Detection and Identification of Candidemia by Direct Blood Culturing on Solid
|
|
- Christopher Gallagher
- 5 years ago
- Views:
Transcription
1 JCM Accepted Manuscript Posted Online 19 October 2016 J. Clin. Microbiol. doi: /jcm Copyright 2016 American Society for Microbiology. 1 2 Rapid Detection and Identification of Candidemia by Direct Blood Culturing on Solid Medium Using Lysis-Centrifugation Method Combined with MALDI-TOF MS Evgeny A. Idelevich, Barbara Grünastel, Karsten Becker# Running title: Direct blood culturing for candidemia diagnostics Affiliation: Institute of Medical Microbiology, University Hospital Münster, Münster, Germany # Address correspondence to Karsten Becker, kbecker@uni-muenster.de (This work was presented in part at the 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen, Denmark, 25 th to 28 th April 2015 [P1077]) 1
2 22 Abstract Candida sepsis is a life-threatening condition with increasing prevalence. In this study, direct blood culturing on solid medium using lysis-centrifugation procedure allowed successful Candida species identification by matrix-assisted laser desorption ionization time-of-flight mass spectrometry on average 3.8 hours (Sabouraud agar) or 7.4 hours (chocolate agar) prior to the positivity signal for control samples in BACTEC Mycosis-IC/F or BACTEC Plus Aerobic/F bottles, respectively. Direct culturing on solid medium accelerates candidemia diagnostics compared to automated broth-based systems. Downloaded from on January 7, 2019 by guest 2
3 Introduction Candidemia is associated with particularly high mortality rate increasingly observed especially among immunocompromised and critically ill patients (1-3). While early and appropriate treatment is vital (3), slow growth of yeasts delays timely diagnosis (4). The current diagnostic standard includes inoculation of patient s blood into special bottles with liquid medium followed by incubation in an automated blood culture (BC) instrument (5). Upon growth detection, Gram stain is performed, and broth is sub-cultivated onto solid medium to grow colonies for identification and antimicrobial susceptibility testing (AST) (4). Lysis-centrifugation blood culture (LC-BC) method is an alternative approach, which has been available for decades, but drifted out of use in the course of blood culture automation (6-9). LC-BC implies selective lysis of blood cells with subsequent centrifugation and culturing of sediment directly on agar plates (6). A recent study has demonstrated that this approach provides a dramatic time reduction in the BC diagnostics for bacteria, when combined with the modern methods of identification and susceptibility testing (10). In this study, we aimed to investigate whether the direct cultivation on solid medium using LC-BC method, combined with the identification by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS), will result in more rapid detection and differentiation of yeasts from blood as compared to the currently used liquid medium-based automated BC instruments. We also investigated impact of specific fungal or general media used with each method. Materials and Methods Four clinical strains of different yeast species were used in the study. Those species included Candida albicans, Candida glabrata, Candida krusei, and Candida tropicalis, as 3
4 confirmed by yeast internal transcribed spacer (ITS) sequencing (11). The strains were subcultured on Sabouraud agar overnight prior to the experiment. Each strain was mixed with 10 ml of human whole blood to produce concentrations 1, 10, and 100 cfu/ml. The exact volume ( µl) of yeast suspension added to the blood was based on the cfu calculations performed in the preliminary experiments for each strain. The actual yeast concentration in the study was confirmed by vital cell count of serial dilutions. 10 ml of inoculated blood was added to Isolator 10 tubes (Wampole Laboratories, Princeton, USA) containing lysis and anticoagulant reagents, followed by centrifugation at 3000g for 30 min. After removal of supernatant, 1.5 ml sediment was vortexed and distributed onto five pre-warmed 150-mm Sabouraud agar plates or five prewarmed 150-mm chocolate agar plates. This processing after centrifugation required approximately several minutes hands-on time per sample. All plates were incubated at 36 C in air with 5% CO 2 to ensure equal atmospheric conditions, which are commonly used when sepsis pathogen is unknown and are reportedly not inhibitory to fungi (12). Visual evaluation of plates was performed hourly beginning from the time of expected appearance of growth as defined in preliminary experiments. Identification by MALDI-TOF MS (Microflex LT, Bruker Daltonics, Bremen, Germany) with on-plate 70% formic acid extraction (13) was performed as soon as microcolonies appeared. The score 1.7 (13) for at least one of three smeared spots was used as criterion for successful species identification. The cultivation time needed for successful identification from microcolonies was recorded. Agar plates were further incubated for a total of 24 hours and MALDI-TOF MS was performed from mature cultures for control. For comparison, 10 ml of inoculated blood were introduced into fungal (BACTEC Mycosis-IC/F, BD Diagnostics, Heidelberg, Germany) and 10 ml into aerobic (BACTEC Plus Aerobic/F, BD Diagnostics) BC bottles, and incubated in the BACTEC 9240 automated BC system (BD Diagnostics). The time to positivity of the automated system was documented. 4
5 Results and discussion The incubation time necessary for species identification by LC-BC method and the time to positivity of the automated BC system are presented in the Table 1, stratified for the different inoculum concentrations as well as for the fungal or general media used. Overall, MALDI-TOF MS identification following the direct blood culturing on Sabouraud agar was achieved before the growth detection in fungal BACTEC bottles for all strains at all yeast concentrations (in average 3.8 h earlier). Also applying general media (chocolate agar and aerobic BACTEC bottle), identification after direct blood culturing was always achieved prior to the growth detection with aerobic BACTEC bottles (in average 7.4 h earlier). Interestingly, the difference between time to successful identification following direct blood culturing on solid medium and time to growth detection by the automated BC system was particularly pronounced for the lowest yeast concentration (1 cfu/ml) (Table 1). This is a relevant finding because the quantitative burden of Candida is very low in the most positive blood cultures (9). Pfeiffer et al. have demonstrated that over half of initial Candida blood cultures have a CFU/ml of 1 (9). There was a pronounced delay of growth detection with C. glabrata by the automated system using aerobic bottle, which occurred for 1 cfu/ml concentration only 26.6 hours after the successful species identification from directly inoculated chocolate agar (Table 1). The delayed detection of C. glabrata using BACTEC Plus Aerobic/F bottle has been previously reported (5, 14). Using the score 1.7 as a criterion for successful identification on species level (13) provided reliable results without misidentifications as compared to ITS sequencing. The growth detection by automated BC systems allows only Gram stain and subcultivation onto agar plates at this time point. Even though direct procedures are available for identification of microorganisms from positive blood culture bottles, they are costly and/or 5
6 laborious and particularly challenging for yeasts (4). Therefore, definitive identification of yeasts in the routine laboratory is still only performed after subsequent incubation of yeasts on agar from grown colonies. In contrast, direct culturing on solid medium provides colonies for immediate testing (15). This means a time advantage of at least one day by using the direct culturing. While Gram stain indicating yeast cells provides important information for initiation of antifungal therapy, species identification and AST results are critical for the administration of appropriate targeted treatment (16). The prevalence of non-albicans Candida spp., particularly C. glabrata, as well as antifungal resistance have been increasing over time (17-19). Occurrence of resistant yeasts including multidrug-resistant strains (20) makes rapid identification and susceptibility testing of fungi isolated from blood essential (18). The availability of colonies on agar is a requirement for definitive testing. While this study didn t additionally investigate the cultivation time needed for initiation of yeast AST, it is obvious that colonies on solid medium could also be used for AST as it has been shown in the previous study with bacteria (10). This study demonstrates that leaving out the incubation of blood samples in liquid medium is beneficial for diagnostics of candidemia as it has been recently demonstrated for bacteremia (10). While the advantages of direct blood culturing on solid medium for detection and identification of yeasts have been pointed out in early publications (6, 7, 21), they are becoming even more obvious in the current era of rapid microbiology. However, technical improvement of the procedure is necessary to ensure contamination-free and easy workflow. In conclusion, direct culturing of blood samples on solid medium allows acceleration of candidemia diagnostics compared to currently applied automated broth-based systems. 6
7 Acknowledgements We are thankful to Katrin Blaschke for expert technical assistance. EAI and KB are inventors of the patent application Apparatus and method for processing of body fluids, owned by the University of Münster. BG declares no conflicts of interest Downloaded from on January 7, 2019 by guest 7
8 133 Table 1. Time to MALDI-TOF MS identification result using lysis-centrifugation direct blood culturing method, in comparison to time to 134 positivity signal of the automated system, hours Fungal media General media Organism Candida albicans Candida glabrata Candida krusei Candida tropicalis Time to species Concentration, identification after cfu/ml direct blood culturing (Sabouraud agar) Time to species Time to positivity Time to positivity identification after signal of automated signal of automated direct blood culturing system (aerobic bottle) system (fungal bottle) (chocolate agar)
9 REFERENCES 1. Lortholary O, Renaudat C, Sitbon K, Madec Y, Denoeud-Ndam L, Wolff M, Fontanet A, Bretagne S, Dromer F Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, ). Intensive Care Med 40: Pfaller M, Neofytos D, Diekema D, Azie N, Meier-Kriesche HU, Quan SP, Horn D Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance ) registry, Diagn. Microbiol. Infect Dis. 74: Kollef M, Micek S, Hampton N, Doherty JA, Kumar A Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin. Infect Dis. 54: Idelevich EA, Grunewald CM, Wüllenweber J, Becker K Rapid identification and susceptibility testing of Candida spp. from positive blood cultures by combination of direct MALDI-TOF mass spectrometry and direct inoculation of Vitek 2. PLoS One. 9:e Köck R, Eissing LC, Boschin MG, Ellger B, Horn D, Idelevich EA, Becker K Evaluation of Bactec Mycosis IC/F and Plus Aerobic/F blood culture bottles for detection of Candida in the presence of antifungal agents. J Clin. Microbiol. 51:
10 Hellinger WC, Cawley JJ, Alvarez S, Hogan SF, Harmsen WS, Ilstrup DM, Cockerill FR, III Clinical comparison of the Isolator and BacT/Alert aerobic blood culture systems. J. Clin. Microbiol. 33: Engler HD, Fahle GA, Gill VJ Clinical evaluation of the BacT/Alert and Isolator aerobic blood culture systems. Am. J. Clin. Pathol. 105: Wasilauskas BL, Morrell R, Jr BacT/Alert and Isolator blood culture systems. Am. J. Clin. Pathol. 107: Pfeiffer CD, Samsa GP, Schell WA, Reller LB, Perfect JR, Alexander BD Quantitation of Candida CFU in initial positive blood cultures. J Clin. Microbiol. 49: Idelevich EA, Grünastel B, Peters G, Becker K Direct blood culturing on solid medium outperforms an automated continuously monitored broth-based blood culture system in terms of time to identification and susceptibility testing. New Microbes New Infect 10: White TJ, Bruns T, Lee S, Taylor J Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics, p In MA Innis, DH Gelfand, JJ Sninsky, TJ White (eds), PCR protocols. A guide to methods and applications. Academic press, San Diego. 2
11 Procop GW, Cockerill FR, III, Vetter EA, Harmsen WS, Hughes JG, Roberts GD Performance of five agar media for recovery of fungi from Isolator blood cultures. J Clin. Microbiol. 38: Theel ES, Schmitt BH, Hall L, Cunningham SA, Walchak RC, Patel R, Wengenack NL Formic acid-based direct, on-plate testing of yeast and Corynebacterium species by Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin. Microbiol. 50: Nawrot U, Kowalska-Krochmal B, Sulik-Tyszka B, Kozak M, Swietek K, Pajaczkowska M, Piatkowska E, Rosiak D, Swoboda-Kopec E Evaluation of blood culture media for the detection of fungi. Eur J Clin. Microbiol. Infect Dis. 34: Wasilauskas BL, Morrell R, Jr Clinical comparison of the Isolator and BacT/Alert aerobic blood culture systems. J Clin. Microbiol. 34: Schmalreck AF, Lackner M, Becker K, Fegeler W, Czaika V, Ulmer H, Lass-Flörl C Phylogenetic relationships matter: antifungal susceptibility among clinically relevant yeasts. Antimicrob Agents Chemother. 58: Wisplinghoff H, Ebbers J, Geurtz L, Stefanik D, Major Y, Edmond MB, Wenzel RP, Seifert H Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities. Int. J Antimicrob Agents 43:
12 Arendrup MC, Perlin DS Echinocandin resistance: an emerging clinical problem? Curr. Opin. Infect Dis. 27: Schmalreck AF, Willinger B, Haase G, Blum G, Lass-Flörl C, Fegeler W, Becker K Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study. Mycoses 55:e124-e Pfaller MA Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am. J Med 125:S Lyon R, Woods G Comparison of the BacT/Alert and Isolator blood culture systems for recovery of fungi. Am. J Clin. Pathol. 103:
MALDI-TOF Mass Spectrometry: A New Rapid ID Method in Clinical Microbiology
MALDI-TOF Mass Spectrometry: A New Rapid ID Method in Clinical Microbiology Patrick R. Murray, PhD WW Director, Scientific Affairs BD Diagnostic Systems Outline MALDI-TOF is the most important innovation
More informationMALDI Sepsityper Kit
Instructions for Use MALDI Sepsityper Kit Kit for identification of microorganisms from positive blood cultures using the MALDI Biotyper system CARE products are designed to support our worldwide customers
More informationAn in-house assay is superior to Sepsityper for the direct MALDI-TOF mass. spectrometry identification of yeast species in blood culture
JCM Accepted Manuscript Posted Online 11 March 2015 J. Clin. Microbiol. doi:10.1128/jcm.03600-14 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 An in-house assay is superior
More informationThe MALDI Biotyper An In Vitro Diagnostic System (IVD) for Identification of Bacteria and Yeasts with a Global Reach
The MALDI Biotyper An In Vitro Diagnostic (IVD) for Identification of Bacteria and Yeasts with a Global Reach The MALDI Biotyper identifies microorganisms using MALDI-TOF (Matrix Assisted Laser Desorption
More information1* 1. Vijaya S. Rajmane, Shivaji T. Mohite
ISSN 2231-4261 ORIGINAL ARTICLE Comparison of the VITEK 2 Yeast Antifungal Susceptibility ing with CLSI Broth Microdilution Reference for ing Four Antifungal Drugs against Candida species Isolated from
More informationon April 30, 2018 by guest
JCM Accepted Manuscript Posted Online 21 October 2015 J. Clin. Microbiol. doi:10.1128/jcm.02024-15 Copyright 2015, American Society for Microbiology. All Rights Reserved. Cost effectiveness of 30-ml blood
More informationComparison of mechanical disruption techniques for the rapid inactivation of
JCM Accepted Manuscript Posted Online 10 August 2016 J. Clin. Microbiol. doi:10.1128/jcm.01096-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 Comparison
More informationFKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia
Clinical Infectious Diseases Advance Access published July 9, 2014 MAJOR ARTICLE FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia Nicholas D. Beyda, 1 Julie John, 1 Abdullah
More informationReceived 12 December 2010/Returned for modification 5 January 2011/Accepted 16 March 2011
JOURNAL OF CLINICAL MICROBIOLOGY, May 2011, p. 1765 1771 Vol. 49, No. 5 0095-1137/11/$12.00 doi:10.1128/jcm.02517-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Multicenter
More informationQuantitation of Candida CFU in Initial Positive Blood Cultures
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 2011, p. 2879 2883 Vol. 49, No. 8 0095-1137/11/$12.00 doi:10.1128/jcm.00609-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Quantitation
More informationMALDI-TOF mass spectrometry tools for microbial identification in archival document investigation
MALDI-TOF mass spectrometry tools for microbial identification in archival document investigation Kateřina Demnerová SMALL GRANT CO-FUNDED BY INTERNATIONAL VISEGRAD FUND Bratislava 31st March 2016 MALDI
More informationAn Update in the Management of Candidiasis
An Update in the Management of Candidiasis Daniel B. Chastain, Pharm.D., AAHIVP Infectious Diseases Pharmacy Specialist Phoebe Putney Memorial Hospital Adjunct Clinical Assistant Professor UGA College
More informationIdentification of Yeasts. Medical Mycology Training Network 15 November 2018 Dr Tan Ai Ling Department of Microbiology, Singapore General Hospital
Identification of Yeasts Medical Mycology Training Network 15 November 2018 Dr Tan Ai Ling Department of Microbiology, Singapore General Hospital Definition of Yeasts Eukaryote cells have defined nucleus
More informationDirect identification of bacteria from positive anaerobic BacT/Alert blood cultures by. Contents Category: Diagnostics, typing and identification
1 2 3 Direct identification of bacteria from positive anaerobic BacT/Alert blood cultures by MALDI-TOF MS: MALDI Sepsityper kit (Bruker) versus in-house saponin method for bacterial extraction 4 5 Running
More informationSYNERGISTIC ACTIVITIES OF TWO PROPOLIS WITH AMPHOTERICIN B AGAINST SOME AZOLE-RESISTANT CANDIDA STRAINS. PART II
SYNERGISTIC ACTIVITIES OF TWO PROPOLIS WITH AMPHOTERICIN B AGAINST SOME AZOLE-RESISTANT CANDIDA STRAINS. PART II DURAN NIZAMI 1, MUZ MUSTAFA 2, DURAN GULAY GULBOL 3, OZER BURCIN 1, ONLEN YUSUF 4 1 Mustafa
More informationDetection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by MALDI- TOF mass spectrometry
JCM Accepts, published online ahead of print on 2 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.01002-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 11 12
More informationBlood culture 壢新醫院 病理檢驗科 陳啟清技術主任
Blood culture 壢新醫院 病理檢驗科 陳啟清技術主任 A Positive Blood Culture Clinically Important Organism Failure of host defenses to contain an infection at its primary focus Failure of the physician to effectively eradicate,
More informationTandem MS in Microbiology. Chris Doern, PhD D(ABMM) UT Southwestern Medical Center Dallas, TX
Tandem MS in Microbiology Chris Doern, PhD D(ABMM) UT Southwestern Medical Center Dallas, TX Learning Objectives After the presentation you should be able to: 1. Understand the mass spectrometry methodology
More informationEchinocandin Susceptibility Testing of Candida Isolates Collected during a 1-Year Period in Sweden
JOURNAL OF CLINICAL MICROBIOLOGY, July 2011, p. 2516 2521 Vol. 49, No. 7 0095-1137/11/$12.00 doi:10.1128/jcm.00201-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Echinocandin
More informationThe microbial diagnosis of infective endocarditis (IE)
The microbial diagnosis of infective endocarditis (IE) Pierrette Melin Medical Microbiology pm-chulg sbimc 10.05.2007 1 Introduction for diagnosis Review of microbiological investigation of IE and perspectives
More informationVIRULENCE FACTORS AND SUSCEPTIBILITY OF CANDIDA SPP. CAUSATIVE AGENTS OF NEONATAL INFECTIONS
VIRULENCE FACTORS AND SUSCEPTIBILITY OF CANDIDA SPP. CAUSATIVE AGENTS OF NEONATAL INFECTIONS Nikola Stojanović, Predrag Stojanović, Suzana Otašević, Valentina Arsić-Arsenijević What do we know? - Third
More informationSpecies Distribution and Antifungal Drug Susceptibility of Candida in Clinical Isolates from a Tertiary Care Centre at Bareilly
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 1 Ver. II (January. 2017), PP 57-61 www.iosrjournals.org Species Distribution and Antifungal
More informationYOTL a procedure for making auxiliary mass spectrum datasets for clinical routine identification of yeasts using the on-target-lysis method
JCM Accepts, published online ahead of print on 17 September 2014 J. Clin. Microbiol. doi:10.1128/jcm.02128-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9
More informationMixInYest: a multicenter survey on mixed yeast infections in Europa
MixInYest: a multicenter survey on mixed yeast infections in Europa COORDINATORS: - Ana Alastruey-Izquierdo, Mycology Reference Laboratory, National Centre for Microbiology, Spain - Cornelia Lass-Flörl,
More informationAntifungal Susceptibility of Bloodstream Candida Isolates in Pediatric Patients
ISSN: 2319-7706 Volume 4 Number 3 (2015) pp. 716-720 http://www.ijcmas.com Original Research Article Antifungal Susceptibility of Bloodstream Candida Isolates in Pediatric Patients Deepak Kumar 1, Sayan
More informationCandida albicans 426 (64.0 ) C. albicans non-albicans
74 2006 1) 2) 1) 3) 4) 5) 6) 1) 2) 3) 4) 5) 6) 17 9 26 18 3 8 2003 10 2004 3 6 9,083 666 (7.3 ) Candida albicans 426 (64.0 ) C. albicans non-albicans 233 (35.0 ) Non-albicans Candida glabrata Candida tropicalis
More informationReceived 18 December 2008/Returned for modification 9 February 2009/Accepted 9 April 2009
JOURNAL OF CLINICAL MICROBIOLOGY, June 2009, p. 1942 1946 Vol. 47, No. 6 0095-1137/09/$08.00 0 doi:10.1128/jcm.02434-08 Copyright 2009, American Society for Microbiology. All Rights Reserved. Activity
More informationWHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS?
WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS? Assoc. Prof. Dr. Serkan SENER Acibadem University Medical School Department of Emergency Medicine, Istanbul Acibadem Ankara Hospital,
More informationMongolia September 2012
MVZ DORTMUND - Dr.Eberhard u. Partner - MICROBIOLOGY MALDI-TOF (MS) evaluation for routine diagnostics MIKROBIOLOGY www.labmed.de / mikro@labmed.de Mongolia September 2012 accreditation since april 2003
More informationReceived 16 February 2011/Returned for modification 16 March 2011/Accepted 26 April 2011
JOURNAL OF CLINICAL MICROBIOLOGY, July 2011, p. 2528 2532 Vol. 49, No. 7 0095-1137/11/$12.00 doi:10.1128/jcm.00339-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Improved Identification
More informationBD Diagnostics Integrated Solutions. Identification and Antimicrobial Susceptibility Testing Diagnostics
BD Diagnostics Integrated Solutions Identification and Antimicrobial Susceptibility Testing Diagnostics Table of contents The threat of antimicrobial resistant bacteria 4 BD Phoenix TM Emerge 5 Financing
More informationIDENTIFICATION OF FUNGAL PATHOGENS BY MALDI-TOF MASS SPECTROMETRY. Alex van Belkum Delhi - March 19, 2015
IDENTIFICATION OF FUNGAL PATHOGENS BY MALDI-TOF MASS SPECTROMETRY Alex van Belkum Delhi - March 19, 2015 1 ASPERGILLUS SPECIES AND GENERA: THE HISTORICAL PERSPECTIVE 70 60 50 40 30 20 10 0 NUMBER OF SPECIES
More informationNational Center for Emerging and Zoonotic Infectious Diseases AR Lab Network Candida Testing
National Center for Emerging and Zoonotic Infectious Diseases AR Lab Network Candida Testing Snigdha Vallabhaneni, MD, MPH Medical Epidemiologist Centers for Disease Control and Prevention Invasive Candidiasis
More information9/18/2018. Invasive Candidiasis. AR Lab Network Candida Testing. Most Common Healthcare Associated Bloodstream Infection in the United States?
National Center for Emerging and Zoonotic Infectious Diseases AR Lab Network Candida Testing Invasive Candidiasis Snigdha Vallabhaneni, MD, MPH Medical Epidemiologist Centers for Disease Control and Prevention
More informationMALDI-TOF MS: Translating Microbiology Laboratory Alphabet Soup to Optimize Antibiotic Therapy
MALDI-TOF MS: Translating Microbiology Laboratory Alphabet Soup to Optimize Antibiotic Therapy September 8, 2017 Amy Carr, PharmD PGY-2 Infectious Diseases Pharmacy Resident Seton Healthcare Family amy.carr@ascension.org
More informationDetermination of MIC & MBC
1 Determination of MIC & MBC Minimum inhibitory concentrations (MICs) are defined as the lowest concentration of an antimicrobial that will inhibit the visible growth of a microorganism after overnight
More information1. Pre-emptive therapy. colonization, colonization, pre-emptive therapy. , ICU colonization. colonization. 2, C. albicans
Jpn. J. Med. Mycol. Vol. 45, 217 221, 2004 ISSN 0916 4804,.,, colonization, pre-emptive therapy. 2, non-albicans Candida., fluconazole.,. Key words: postoperative infection, non-albicans Candida, pre-emptive
More informationMatrix-assisted laser desorption/ionization time-of-flight mass spectrometry for the identification of beta-hemolytic streptococci
Original Article Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for the identification of beta-hemolytic streptococci Chunmei Zhou 1 *, Lili Tao 2 *, Bijie Hu 3, Jian Ma 4,
More informationAntifungal susceptibility testing: Which method and when?
Antifungal susceptibility testing: Which method and when? Maiken Cavling Arendrup mad@ssi.dk SSI & Juan Luis Rodriguez Tudela jlrtudela@isciii.es ISCIII Agenda Summary of current standards and selected
More informationClinical Microbiology
Clinical Microbiology MALDI Biotyper Fast & Accurate Identification of Microorganisms Innovation with Integrity MALDI-TOF In Microbiology, Every Minute Counts A Powerful Technology for Better Results To
More informationEffects of Blood Volume Monitoring on the Rate of Positive Blood Cultures from the Emergency Room
Ann Clin Microbiol Vol. 19, No. 3, September, 2016 http://dx.doi.org/10.5145/acm.2016.19.3.70 pissn 2288-0585 eissn 2288-6850 Effects of Blood Volume Monitoring on the Rate of Positive Blood Cultures from
More informationReceived 4 August 2010/Returned for modification 23 October 2010/Accepted 19 November 2010
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 2011, p. 561 566 Vol. 55, No. 2 0066-4804/11/$12.00 doi:10.1128/aac.01079-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Candida
More informationMALDI-TOF mass spectrometry for direct bacterial identification
JCM Accepts, published online ahead of print on 17 February 2010 J. Clin. Microbiol. doi:10.1128/jcm.01780-09 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationTable 1. Antifungal Breakpoints for Candida. 2,3. Agent S SDD or I R. Fluconazole < 8.0 mg/ml mg/ml. > 64 mg/ml.
AUSTRALIAN ANTIFUNGAL SUSCEPTIBILITY DATA 2008-2011 Part 1: The Yeasts In this article, an update of recent changes to the CLSI antifungal standards for susceptibility testing of yeasts is presented. We
More informationOVERVIEW OF CURRENT IDENTIFICATION SYSTEMS AND DATABASES
OVERVIEW OF CURRENT IDENTIFICATION SYSTEMS AND DATABASES EVERY STEP OF THE WAY 1 EVERY STEP OF THE WAY MICROBIAL IDENTIFICATION METHODS DNA RNA Genotypic Sequencing of ribosomal RNA regions of bacteria
More informationReceived 31 March 2009/Returned for modification 26 May 2009/Accepted 22 June 2009
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2009, p. 2766 2771 Vol. 47, No. 9 0095-1137/09/$08.00 0 doi:10.1128/jcm.00654-09 Copyright 2009, American Society for Microbiology. All Rights Reserved. Comparison
More informationResearch Article Comparative Evaluation of the BD Phoenix Yeast ID Panel and Remel RapID Yeast Plus System for Yeast Identification
Canadian Infectious Diseases and Medical Microbiology Volume 2016, Article ID 4094932, 4 pages http://dx.doi.org/10.1155/2016/4094932 Research Article Comparative Evaluation of the BD Phoenix Yeast ID
More informationPREVALANCE OF CANDIDIASIS IN CHILDREN IN MUMBAI
Shrutika Wandre et al. Special Issue, 2015, pp. 25-36 PREVALANCE OF CANDIDIASIS IN CHILDREN IN MUMBAI Shrutika Wandre Department of Clinical Pathology, Haffkine Institute for Training, Research and Testing,
More informationValidation of the MALDI-TOF for the Identification of Neisseria gonorrhoeae
Proposal Validation of the MALDI-TOF for the Identification of Neisseria gonorrhoeae Laboratory Director Sandip H. Shah, Ph.D. 517-335-8063 517-335-8051 (fax) ShahS@Michigan.gov Acting Director, Division
More informationCD101: A Novel Echinocandin
CD101: A Novel Echinocandin Taylor Sandison, MD MPH Chief Medical Officer TIMM Belgrade, Serbia October 8, 2017 1 Disclosures Dr. Sandison is an employee of and stockholder in Cidara Therapeutics 2 Cidara
More informationCONSIDERATIONS IN UTI DETECTION AND POTENTIAL IMPACT ON ANTIBIOTIC STEWARDSHIP
CONSIDERATIONS IN UTI DETECTION AND POTENTIAL IMPACT ON ANTIBIOTIC STEWARDSHIP ERIN H. GRAF, PHD, D(ABMM) Director, Infectious Disease Diagnostics Laboratory Assistant Professor, Clinical Pathology and
More informationMedical Microbiology, University Hospital of Liège, Liège, Belgium
Journal of Medical Microbiology (2012), 61, 1511 1516 DOI 10.1099/jmm.0.044750-0 Direct identification of bacteria from BacT/ALERT anaerobic positive blood cultures by MALDI-TOF MS: MALDI Sepsityper kit
More informationLaboratory Identification of Leptotrichia Species Isolated From Bacteremia Patients at a Single Institution
Brief Communication Clinical Microbiology Ann Lab Med 2017;37:272-276 https://doi.org/10.3343/alm.2017.37.3.272 ISSN 2234-3806 eissn 2234-3814 Laboratory Identification of Leptotrichia Species Isolated
More informationFungal infections in ICU. Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia
Fungal infections in ICU Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia Epidemiology of invasive fungal infections - US +300% Martin GS, et al. N Engl J Med 2003;348:1546-1554
More informationImpact of Antimicrobial Stewardship Intervention on Coagulase-Negative Staphylococcus Blood. Cultures in Conjunction with Rapid Diagnostic Testing
JCM Accepts, published online ahead of print on 28 May 2014 J. Clin. Microbiol. doi:10.1128/jcm.00682-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 2 Impact of Antimicrobial
More informationIdentification of Mycoplasma spp. using MALDI-TOF Mass Spectrometry. Aric McDaniel
Identification of Mycoplasma spp. using MALDI-TOF Mass Spectrometry Aric McDaniel Outline Background Information Introduction Methods Results Conclusion Next Steps Mycoplasma spp. Lack a cell wall Among
More informationMicafungin and Candida spp. Rationale for the EUCAST clinical breakpoints. Version February 2013
Micafungin and Candida spp. Rationale for the EUCAST clinical breakpoints. Version 1.0 5 February 2013 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised
More informationThe Effect of Cilofungin (LY ) in Combination with Amphotericin B
rnycoses 32 (3) 151-157. accepted/angenommen: October 3,1988. 0 Grosse Verlag Berlin 1989 The Effect of Cilofungin (LY 121019) in Combination with Amphotericin B or Flucytosine Against Candida Species
More informationESCMID Online Lecture Library. by author
Microbiological evaluation: how to report the results Alvaro Pascual MD, PhD Infectious Diseases and Clinical Microbiology Unit. University Hospital Virgen Macarena University of Sevilla BSI management
More informationUse of Antifungal Drugs in the Year 2006"
Use of Antifungal Drugs in the Year 2006" Jose G. Montoya, MD Associate Professor of Medicine Associate Chief for Clinical Affairs Division of Infectious Diseases Stanford University School of Medicine
More information320 MBIO Microbial Diagnosis. Aljawharah F. Alabbad Noorah A. Alkubaisi 2017
320 MBIO Microbial Diagnosis Aljawharah F. Alabbad Noorah A. Alkubaisi 2017 Blood Culture What is a blood culture? A blood culture is a laboratory test in which blood is injected into bottles with culture
More informationEfficacy of a Novel Echinocandin, CD101, in a Mouse Model of Azole-Resistant Disseminated Candidiasis
Efficacy of a Novel Echinocandin, CD0, in a Mouse Model of Azole-Resistant Disseminated Candidiasis L. Miesel, K-Y Lin, J. C. Chien, M. L. Hsieh, V. Ong, and K. Bartizal Eurofins Panlabs, Taipei, Taiwan
More informationFungi GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 53: Author Moi Lin Ling, MBBS, FRCPA, CPHQ, MBA
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 53: Fungi Author Moi Lin Ling, MBBS, FRCPA, CPHQ, MBA Chapter Editor Ziad A. Memish, MD, FRCPC, FACP Cover heading - Topic Outline Topic outline
More informationTerapia della candidiasi addomaniale
Verona 16 marzo 2018 Terapia della candidiasi addomaniale Pierluigi Viale Infectious Disease Unit Teaching Hospital S. Orsola Malpighi Bologna INTRA ABDOMINAL CANDIDIASIS open questions a single definition
More informationSusceptibility of Candida Species Isolated From HIV Infected and Newborn Candidaemia Patients to Amphotericin B
OnLine Journal of Biological Sciences 10 (2): 109-113, 2010 ISSN 1608-4217 2010 Science Publications Susceptibility of Candida Species Isolated From HIV Infected and Newborn Candidaemia Patients to Amphotericin
More informationResistance epidemiology
ECMM/EFISG symposium: Multidrug resistance in fungi? A formidable foe Resistance epidemiology Ana Alastruey Izquierdo Mycology Reference Lab Spain Instituto de Salud Carlos III Disclousure I have received
More informationOverview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing
Overview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing 1. Essentials for the Mycobacteriology Laboratory: Promoting Quality Practices 1.1 Overview: Mycobacterial Culture, Identification,
More informationdida tropicalis, Candida parapsilosis, Candida krusei, Cr. neoformans
dida tropicalis, Candida parapsilosis, Candida krusei, Cr. neoformans Key words: Susceptibility test, IC99, miconazole, fluconazole, itraconazole, Micro-dilution method, 96-multiwell plate Table 1. Cunteffis
More informationCandida auris: an Emerging Hospital Infection
National Center for Emerging and Zoonotic Infectious Diseases Candida auris: an Emerging Hospital Infection Paige Armstrong MD MHS Epidemic Intelligence Service Officer Mycotic Diseases Branch Association
More informationon December 9, 2018 by guest
JCM Accepts, published online ahead of print on 27 June 2012 J. Clin. Microbiol. doi:10.1128/jcm.00937-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Progress in Antifungal
More informationUse of the BacT/ALERT MB Mycobacteria Blood Culture System for Detecting ACCEPTED
JCM Accepts, published online ahead of print on December 00 J. Clin. Microbiol. doi:.11/jcm.011-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
More informationRamanath Karicheri 1, Beena Antony 2* Original Research Article. Abstract
Original Research Article Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) for the proteomic based identification of Aggregatibacter actinomycetemcomitans isolated
More informationCandidemia: New Sentinel Surveillance in the 7-County Metro
Candidemia: New Sentinel Surveillance in the 7-County Metro Brittany VonBank, MPH Paula Vagnone, MT (ASCP) 651-201-5414 www.health.state.mn.us Health Care-associated Infections & Antimicrobial Resistance
More informationUpdate zu EUCAST 2012 Cornelia Lass-Flörl
Update zu EUCAST 2012 Cornelia Lass-Flörl Frühjahrstagung 2012 Paul-Ehrlich-Gesellschaft Sektion Antimykotische Chemotherapie Bonn, 4./5. Mai 2012 Agenda 1. Breakpoints 2. Rationale documents and technical
More informationIdentification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey
DOI 10.1186/s12941-016-0153-1 Annals of Clinical Microbiology and Antimicrobials RESEARCH Open Access Identification and antifungal susceptibility of Candida species isolated from bloodstream infections
More informationMANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS
MANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS Paul D. Holtom, MD Associate Professor of Medicine and Orthopaedics USC Keck School of Medicine Numbers of Cases of Sepsis in the United States, According
More information5-Fluorocytosine resistance in clinical isolates of cryptococcus neoformans
Med. J. Malaysia Vol. 44 No. 3 September 1989 5-Fluorocytosine resistance in clinical isolates of cryptococcus neoformans C.S. Chin, B Se (Hons) Y.M. Cheong, MBBS, M Se Bacteriology Division Institute
More informationDetection of microorganisms in blood specimens using matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a review
REVIEW 10.1111/j.1469-0691.2010.03290.x Detection of microorganisms in blood specimens using matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a review M. Drancourt Unité de
More informationMay 11, Ceftriaxone for MSSA. Daptomycin Dosing Weight. Candidiasis Treatment
Diagnostics and Debates: An Update on Rapid Diagnostic Testing and Current Controversies in Infectious Diseases Nicholas Torney, PharmD, BCPS Derek Vander Horst, PharmD Munson Medical Center WMSHP Annual
More informationon December 11, 2018 by guest
JCM Accepts, published online ahead of print on 12 December 2012 J. Clin. Microbiol. doi:10.1128/jcm.03125-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 Biographical Feature;
More informationRapid identification and resistance assessment: The future is mass spectrometry
Rapid identification and resistance assessment: The future is mass spectrometry Dr Sanmarié Schlebusch Director of Microbiology Mater Pathology Brisbane Outline Introduction Plug and play Pre-prep and
More informationISSN Vol.02,Issue.19, December-2013, Pages:
www.semargroups.org, www.ijsetr.com ISSN 2319-8885 Vol.02,Issue.19, December-2013, Pages:2180-2185 Studies on Antifungal Properties of Some Plant Extracts (Garlic, Fenugreek, Ginger) Against of Clinical
More informationGlobal trends in the distribution of Candida species causing candidemia
REVIEW 10.1111/1469-0691.12539 Global trends in the distribution of Candida species causing candidemia J. Guinea 1,2,3,4 1) Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario
More informationPREVALANCE OF CANDIDIASIS IN CHILDREN IN MUMBAI
Wandre et al., 2015 Volume 1 Issue 1, pp. 25-36 Year of Publication: 2015 DOI- https://dx.doi.org/10.20319/lijshls.2015.s11.2536 This paper can be cited as: Wandre, S., Sanap, S., Mukadam, T., Vaidya,
More informationEvaluation of Antibacterial Effect of Odor Eliminating Compounds
Evaluation of Antibacterial Effect of Odor Eliminating Compounds Yuan Zeng, Bingyu Li, Anwar Kalalah, Sang-Jin Suh, and S.S. Ditchkoff Summary Antibiotic activity of ten commercially available odor eliminating
More informationBrief Communication Clinical Microbiology
Brief Communication Clinical Microbiology Ann Lab Med 2017;37:531-535 https://doi.org/10.3343/alm.2017.37.6.531 ISSN 2234-3806 eissn 2234-3814 Comparison of a New Matrix-Assisted Laser Desorption/Ionization
More informationComparison of Two Laboratory Techniques for Detecting Mycoplasmas in Genital Specimens. Osama Mohammed Saed Abdul-Wahab, BSc, MSc, PhD*
Bahrain Medical Bulletin, Vol. 32, No. 4, December 200 Comparison of Two Laboratory Techniques for Detecting Mycoplasmas in Genital Specimens Osama Mohammed Saed Abdul-Wahab, BSc, MSc, PhD* Objective:
More informationFungal Infection in the ICU: Current Controversies
Fungal Infection in the ICU: Current Controversies Andrew F. Shorr, MD, MPH, FCCP, FACP Washington Hospital Center Georgetown University, Washington, DC Disclosures I have served as a consultant to, researcher/investigator
More informationLa «Fast Microbiology» applicata alla sepsi: prospettive ed opportunità
La «Fast Microbiology» applicata alla sepsi: prospettive ed opportunità Maurizio Sanguinetti Istituto di Microbiologia Fondazione Policlinico Universitario «A. Gemelli» - IRCCS Rapid diagnostic tests:
More informationMALDI-TOF MS: a new tool to rapidly assess antibiotic susceptibility
MALDI-TOF MS: a new tool to rapidly assess antibiotic susceptibility Sören Schubert, MD Max von Pettenkofer-Institut Ludwig-Maximilians-University (LMU) Munich, Germany Learning Objectives After this presentation,
More informationCost Analysis of Implementing MALDI-TOF plus Real-time Antimicrobial Stewardship
JCM Accepted Manuscript Posted Online 19 October 2016 J. Clin. Microbiol. doi:10.1128/jcm.01452-16 Copyright 2016 American Society for Microbiology. 1 2 Cost Analysis of Implementing MALDI-TOF plus Real-time
More informationVITEK MS Implementation of Mass Spectrometry
VITEK MS Implementation of Mass Spectrometry Willson Jang, Technical Leader wljang@providencehealth.bc.ca Microbiology & Virology Laboratory Providence Health Care St. Paul s Hospital October 23, 2013
More informationBiological Consulting Services
Biological Consulting Services of North Florida/ Inc. May 13, 2009 Aphex BioCleanse Systems, Inc. Dear Sirs, We have completed antimicrobial efficacy study on the supplied Multi-Purpose Solution. The testing
More informationAntifungal Pharmacodynamics A Strategy to Optimize Efficacy
Antifungal Pharmacodynamics A Strategy to Optimize Efficacy David Andes, MD Associate Professor, Department of Medicine Division of Infectious Diseases Medical Microbiology and Immunology University of
More informationLab 4. Blood Culture (Media) MIC AMAL-NORA-ALJAWHARA 1
Lab 4. Blood Culture (Media) 2018 320 MIC AMAL-NORA-ALJAWHARA 1 Blood Culture 2018 320 MIC AMAL-NORA-ALJAWHARA 2 What is a blood culture? A blood culture is a laboratory test in which blood is injected
More informationMALDI Biotyper Quick Guide for Food Testing Edition 1, Innovation with Integrity MALDI-TOF
MALDI Biotyper Quick Guide for Food Testing Edition 1, 2018 Innovation with Integrity MALDI-TOF MALDI Biotyper Quick Guide for Food Testing Confirmation of foodborne pathogens, confirmation of quality
More informationRapid detection of carbapenemase-producing Enterobacteriaceae from blood cultures
ORIGINAL ARTICLE BACTERIOLOGY Rapid detection of carbapenemase-producing Enterobacteriaceae from blood cultures L. Dortet 1,L.Brechard 1, L. Poirel 1,2 and P. Nordmann 1,2 1) Service de Bacteriologie-Virologie,
More informationRESEARCH ARTICLE Torres et al., Journal of Medical Microbiology 2017;66: DOI /jmm
RESEARCH ARTICLE Torres et al., Journal of Medical Microbiology 2017;66:1752 1758 DOI 10.1099/jmm.0.000643 Short-term incubation of positive blood cultures in brain-heart infusion broth accelerates identification
More information